Award-Winning Actor Danny Glover Featured on 'Sharing Miracles'

Award-Winning Actor Danny Glover Featured on 'Sharing Miracles'

WASHINGTON, Oct. 23 /PRNewswire-USNewswire/ -- A recent edition of Immunotherapy Weekly reported that the television program 'Sharing Miracles' featured award-winning actor Danny Glover during the month of September. In this episode, the Hollywood star discussed his career and his battle against epilepsy.

Danny Glover is probably best known for his role as Detective Murtaugh in the Lethal Weapon movie series. Less known to his fans may be the fact that Glover struggled with epilepsy for 20 years.

Glover experienced his first epileptic seizure when he was 15 years old. Despite many tests, it wasn't until he suffered from several more seizures that he was diagnosed with epilepsy and treated with medication. Fortunately, Glover was able to control his illness and build an impressive acting career - appearing in dozens of movies including The Color Purple, Places in the Heart, The Royal Tenenbaums and Dreamgirls, among others.

After 20 years, for reasons unknown, Glover stopped experiencing seizures. However, other epilepsy patients are not so lucky.

According to the Epilepsy Foundation, more than 2.5 million Americans suffer from the disease, with more than 108,000 diagnoses each year. Fortunately, America's pharmaceutical research and biotechnology companies have more than 540 medicines in development to treat debilitating neurological disorders such as epilepsy.

'Sharing Miracles' is a 30-minute public affairs television program that tells the compelling and inspirational stories of real patients. Sharing Miracles airs every Sunday morning on more than 300 television stations nationwide. The program is produced by the Pharmaceutical Research and Manufacturers of America (PhRMA).

PhRMA represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives.

To read the original article in Immunotherapy Weekly, visit the publication's website.

First Call Analyst:
FCMN Contact:

Source: Pharmaceutical Research and Manufacturers of America

CONTACT: Lauren Mullins, +1-202-683-3115, lmullins@qorvis.com, for
Pharmaceutical Research and Manufacturers of America

Web Site: http://www.phrma.org/

---

Profile: International Entertainment